Laura G. Forti - Publications

A phase III randomized clinical trial of Gemcitabine and Nab-Paclitaxel as switch maintenance versus continuation of modified FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: The PANThEON Study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: September 13, 2025

Cartoon: multicenter prospective observational study of Cardiovascular Toxicity of Trifluridine/Tipiracil in metastatic colorectal cancer.

Journal: The oncologist

Published: January 03, 2025

Management of intrahepatic cholangiocarcinoma: a review for clinicians.

Journal: Gastroenterology report

Published: August 30, 2024

Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants.

Journal: Cancer medicine

Published: January 14, 2024

Capecitabine-Induced Ileitis during Neoadjuvant Pelvic Radio-Chemotherapy for Locally Advanced Rectal Cancer: A Case Report with Literature Review.

Journal: Current oncology (Toronto, Ont.)

Published: September 25, 2023

Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv).

Journal: British journal of cancer

Published: April 15, 2022

MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression.

Journal: International journal of clinical oncology

Published: May 18, 2017

Primary Ewing's sarcoma of the sinonasal tract, eroding the ethmoid and sphenoid sinus with intracranial extension: A rare case report.

Journal: Molecular and clinical oncology

Published: February 26, 2015

The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study.

Journal: The oncologist

Published: September 08, 2012